ClinicalTrials.Veeva

Menu

Breath Analysis Based Disease Biomarkers

Mayo Clinic logo

Mayo Clinic

Status

Completed

Conditions

COVID19
Liver Cancer
Liver Diseases

Treatments

Diagnostic Test: Collection of breath sample

Study type

Observational

Funder types

Other

Identifiers

NCT04341012
19-001971

Details and patient eligibility

About

The purpose of the study is to develop a clinical test based on breath analysis that can be used for disease diagnosis or prognosis.

Full description

The study will seek to collect and analyze breath samples from a broad range of patients to develop reference ranges and to refine the testing methods. Protocols for breath sample collection and algorithms for analysis will be developed. Samples will be collected from normal volunteers, persons with documented liver disease, organ transplant or with known COVID-19 test results.

Enrollment

46 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Able to provide informed consent

Exclusion criteria

  • None

Trial design

46 participants in 4 patient groups

Normal
Description:
No known medical conditions
Treatment:
Diagnostic Test: Collection of breath sample
Liver Cirrhosis
Description:
Clinically diagnosed with cirrhosis
Treatment:
Diagnostic Test: Collection of breath sample
COVID-19 tested
Description:
Persons with known test results for COVID-19 RNA
Treatment:
Diagnostic Test: Collection of breath sample
Other
Description:
Persons with other medical diagnosis, no known liver disease, negative for COVID-19
Treatment:
Diagnostic Test: Collection of breath sample

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems